NCT02230202View on ClinicalTrials.gov

Endothelial Microparticles: A Novel Marker of Vascular Dysfunction

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Chronic Kidney Disease
Interventions
OTHER

Flow-mediated dilation

Flow-mediated dilation used to measure vascular function. The test is minimally invasive, with only a slight discomfort due to the inflation of the arm cuff.

OTHER

single blood draw

single blood draw of approximately 45 mL.

Trial Locations (2)

80045

University of Colorado Anschutz Medical Campus; CTRC, Aurora

University of Colorado School of Medicine, Aurora

All Listed Sponsors
lead

University of Colorado, Denver

OTHER

NCT02230202 - Endothelial Microparticles: A Novel Marker of Vascular Dysfunction | Biotech Hunter | Biotech Hunter